{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:38:46Z","timestamp":1709167126155},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,28]]},"DOI":"10.7759\/cureus.55154","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T17:26:27Z","timestamp":1709141187000},"source":"Crossref","is-referenced-by-count":0,"title":["Review of the Association Between Long-Term and Current Systemic Steroid Use With Electromechanical Complications and Inpatient Mortality After ST-Elevation Myocardial Infarction"],"prefix":"10.7759","author":[{"given":"Dennis D","family":"Kumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T","family":"Narh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Gwira-Tamattey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Sana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana Yaa","family":"Ampaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Oduro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel M","family":"Odoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheriff","family":"Dodoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setri","family":"Fugar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams DM","year":"2018","unstructured":"Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018, 63:655-670. 10.4187\/respcare.06314","journal-title":"Respir Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille C","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, et al.. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015, 74:480-489. 10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nm0502-473","article-title":"Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase","volume":"8","author":"Hafezi-Moghadam A","year":"2002","unstructured":"Hafezi-Moghadam A, Simoncini T, Yang Z, et al.. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002, 8:473-479. 10.1038\/nm0502-473","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107221","article-title":"Reduction of experimental myocardial infarct size by corticosteroid administration","volume":"52","author":"Libby P","year":"1973","unstructured":"Libby P, Maroko PR, Bloor CM, Sobel BE, Braunwald E. Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest. 1973, 52:599-607. 10.1172\/JCI107221","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.53.5.847","article-title":"Myocardial reperfusion in acute experimental ischemia. Beneficial effects of prior treatment with steroids","volume":"53","author":"da Luz PL","year":"1976","unstructured":"da Luz PL, Forrester JS, Wyatt HL, Diamond GA, Chag M, Swan HJ. Myocardial reperfusion in acute experimental ischemia. Beneficial effects of prior treatment with steroids. Circulation. 1976, 53:847-852. 10.1161\/01.cir.53.5.847","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2022.09.003","article-title":"Management and long-term outcomes of patients with chronic inflammatory diseases experiencing ST-segment elevation myocardial infarction: the SCALIM registry","volume":"115","author":"Boukhris M","year":"2022","unstructured":"Boukhris M, Dupire N, Dousset B, Pradel V, Virot P, Magne J, Aboyans V. Management and long-term outcomes of patients with chronic inflammatory diseases experiencing ST-segment elevation myocardial infarction: the SCALIM registry. Arch Cardiovasc Dis. 2022, 115:647-655. 10.1016\/j.acvd.2022.09.003","journal-title":"Arch Cardiovasc Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e328364100b","article-title":"Plasma cortisol and prognosis of patients with acute myocardial infarction","volume":"15","author":"Jutla SK","year":"2014","unstructured":"Jutla SK, Yuyun MF, Quinn PA, Ng LL. Plasma cortisol and prognosis of patients with acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2014, 15:33-41. 10.2459\/JCM.0b013e328364100b","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.05.019","article-title":"Use of oral corticosteroids and the risk of acute myocardial infarction","volume":"192","author":"Varas-Lorenzo C","year":"2007","unstructured":"Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Gutthann S. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis. 2007, 192:376-383. 10.1016\/j.atherosclerosis.2006.05.019","journal-title":"Atherosclerosis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00095909","article-title":"Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD","volume":"35","author":"Loke YK","year":"2010","unstructured":"Loke YK, Kwok CS, Singh S. Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD. Eur Respir J. 2010, 35:1003-1021. 10.1183\/09031936.00095909","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.08.016","article-title":"Inhaled corticosteroid\/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients","volume":"47","author":"Contoli M","year":"2018","unstructured":"Contoli M, Campo G, Pavasini R, et al.. Inhaled corticosteroid\/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. Eur J Intern Med. 2018, 47:82-86. 10.1016\/j.ejim.2017.08.016","journal-title":"Eur J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(03)00148-6","article-title":"Meta-analysis of corticosteroid treatment in acute myocardial infarction","volume":"91","author":"Giugliano GR","year":"2003","unstructured":"Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol. 2003, 91:1055-1059. 10.1016\/s0002-9149(03)00148-6","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.09.011","article-title":"The effect of low-dose colchicine in patients with stable coronary artery disease: the LoDoCo2 trial rationale, design, and baseline characteristics","volume":"218","author":"Nidorf SM","year":"2019","unstructured":"Nidorf SM, Fiolet AT, Eikelboom JW, et al.. The effect of low-dose colchicine in patients with stable coronary artery disease: the LoDoCo2 trial rationale, design, and baseline characteristics. Am Heart J. 2019, 218:46-56. 10.1016\/j.ahj.2019.09.011","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui N","year":"2020","unstructured":"Bouabdallaoui N, Tardif JC, Waters DD, et al.. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J. 2020, 41:4092-4099. 10.1093\/eurheartj\/ehaa659","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis NG","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014, 11:255-265. 10.1038\/nrcardio.2014.28","journal-title":"Nat Rev Cardiol"},{"key":"ref15","unstructured":"Healthcare Cost and Utilization Project. Introduction to the HCUP National Inpatient Sample 2017. (2020). Accessed. June 29, 2020: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/NIS_Introduction_2017.jsp."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman RA","year":"2013","unstructured":"Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2013, 65:294-298. 10.1002\/acr.21796","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet L","year":"2011","unstructured":"Fardet L, Petersen I, Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology (Oxford). 2011, 50:1982-1990. 10.1093\/rheumatology\/ker017","journal-title":"Rheumatology (Oxford)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4052-y","article-title":"Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient","volume":"19","author":"Nogu\u00e9 M","year":"2019","unstructured":"Nogu\u00e9 M, Rambaud J, Fabre S, Filippi N, Jorgensen C, Pers YM. Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient. BMC Health Serv Res. 2019, 19:255. 10.1186\/s12913-019-4052-y","journal-title":"BMC Health Serv Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0022146518784592","article-title":"Racial-ethnic disparities in inflammation: evidence of weathering in childhood?","volume":"59","author":"Schmeer KK","year":"2018","unstructured":"Schmeer KK, Tarrence J. Racial-ethnic disparities in inflammation: evidence of weathering in childhood?. J Health Soc Behav. 2018, 59:411-428. 10.1177\/0022146518784592","journal-title":"J Health Soc Behav"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.101005","article-title":"Trends in clinical characteristics and outcomes in ST-elevation myocardial infarction hospitalizations in the United States, 2002-2016","volume":"47","author":"Ahuja KR","year":"2022","unstructured":"Ahuja KR, Saad AM, Nazir S, et al.. Trends in clinical characteristics and outcomes in ST-elevation myocardial infarction hospitalizations in the United States, 2002-2016. Curr Probl Cardiol. 2022, 47:101005. 10.1016\/j.cpcardiol.2021.101005","journal-title":"Curr Probl Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.14.1562","article-title":"Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial","volume":"297","author":"Halonen J","year":"2007","unstructured":"Halonen J, Halonen P, J\u00e4rvinen O, et al.. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA. 2007, 297:1562-1567. 10.1001\/jama.297.14.1562","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019837","article-title":"Post-cardiac arrest hydrocortisone use ameliorates cardiac mitochondrial injury in a male rat model of ventricular fibrillation cardiac arrest","volume":"10","author":"Tsai MS","year":"2021","unstructured":"Tsai MS, Huang CH, Wang CH, Cheng HJ, Wu SN, Chang WT, Chen WJ. Post-cardiac arrest hydrocortisone use ameliorates cardiac mitochondrial injury in a male rat model of ventricular fibrillation cardiac arrest. J Am Heart Assoc. 2021, 10:e019837. 10.1161\/JAHA.120.019837","journal-title":"J Am Heart Assoc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(55)90183-6","article-title":"Adrenal steroids and auriculoventricular conduction","volume":"50","author":"Lown B","year":"1955","unstructured":"Lown B, Arons WL, Ganong WF, Vazifdar JP, Levine SA. Adrenal steroids and auriculoventricular conduction. Am Heart J. 1955, 50:760-769. 10.1016\/0002-8703(55)90183-6","journal-title":"Am Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2006.02.013","article-title":"Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I","volume":"132","author":"Whitlock RP","year":"2006","unstructured":"Whitlock RP, Young E, Noora J, Farrokhyar F, Blackall M, Teoh KH. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I. J Surg Res. 2006, 132:188-194. 10.1016\/j.jss.2006.02.013","journal-title":"J Surg Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.01.045","article-title":"Outcomes of percutaneous coronary intervention in patients with acquired immunosuppression","volume":"171","author":"Doolub G","year":"2022","unstructured":"Doolub G, Kobo O, Mohamed MO, et al.. Outcomes of percutaneous coronary intervention in patients with acquired immunosuppression. Am J Cardiol. 2022, 171:40-48. 10.1016\/j.amjcard.2022.01.045","journal-title":"Am J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.61.5.488","article-title":"Use of hydrocortisone in the treatment of acute myocardial infarction: summary of a clinical trial in 446 patients","volume":"61","author":"Barzilai D","year":"1972","unstructured":"Barzilai D, Plavnick J, Hazani A, Einath R, Kleinhaus N, Kanter Y. Use of hydrocortisone in the treatment of acute myocardial infarction: summary of a clinical trial in 446 patients. Chest. 1972, 61:488-491. 10.1378\/chest.61.5.488","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5681\/jcvtr.2012.026","article-title":"Serum cortisol levels as a predictor of neurologic survival in successfully resuscitated victims of cardiopulmonary arrest","volume":"4","author":"Tavakoli N","year":"2012","unstructured":"Tavakoli N, Bidari A, Shams Vahdati S. Serum cortisol levels as a predictor of neurologic survival in successfully resuscitated victims of cardiopulmonary arrest. J Cardiovasc Thorac Res. 2012, 4:107-111. 10.5681\/jcvtr.2012.026","journal-title":"J Cardiovasc Thorac Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-10-0652","article-title":"High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men","volume":"94","author":"Jilma B","year":"2005","unstructured":"Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD. High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost. 2005, 94:797-801. 10.1160\/TH04-10-0652","journal-title":"Thromb Haemost"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2005.06.006","article-title":"Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers","volume":"118","author":"Brotman DJ","year":"2006","unstructured":"Brotman DJ, Girod JP, Posch A, et al.. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res. 2006, 118:247-252. 10.1016\/j.thromres.2005.06.006","journal-title":"Thromb Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon DM","year":"2007","unstructured":"Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007, 357:1121-1135. 10.1056\/NEJMra071667","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.61.1.20","article-title":"Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog","volume":"61","author":"Engler R","year":"1987","unstructured":"Engler R, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res. 1987, 61:20-28. 10.1161\/01.res.61.1.20","journal-title":"Circ Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.146.6.1693","article-title":"Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors","volume":"146","author":"Granelli-Piperno A","year":"1977","unstructured":"Granelli-Piperno A, Vassalli JD, Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med. 1977, 146:1693-1706. 10.1084\/jem.146.6.1693","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/cc11467","article-title":"Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction","volume":"16","author":"Andri\u00e9 RP","year":"2012","unstructured":"Andri\u00e9 RP, Becher UM, Frommold R, Tiyerili V, Schrickel JW, Nickenig G, Schwab JO. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care. 2012, 16:R152. 10.1186\/cc11467","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000155614.35441.69","article-title":"Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study","volume":"111","author":"Valgimigli M","year":"2005","unstructured":"Valgimigli M, Ceconi C, Malagutti P, et al.. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation. 2005, 111:863-870. 10.1161\/01.CIR.0000155614.35441.69","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103\/1995-705X.96660","article-title":"C-reactive protein as a predictor of adverse outcome in patients with acute coronary syndrome","volume":"13","author":"Sheikh AS","year":"2012","unstructured":"Sheikh AS, Yahya S, Sheikh NS, Sheikh AA. C-reactive protein as a predictor of adverse outcome in patients with acute coronary syndrome. Heart Views. 2012, 13:7-12. 10.4103\/1995-705X.96660","journal-title":"Heart Views"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.2.149","article-title":"Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling","volume":"98","author":"Ono K","year":"1998","unstructured":"Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation. 1998, 98:149-156. 10.1161\/01.cir.98.2.149","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)02251-2","article-title":"Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction","volume":"89","author":"Takahashi M","year":"2002","unstructured":"Takahashi M, Nishihira J, Katsuki T, Kobayashi E, Ikeda U, Shimada K. Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol. 2002, 89:248-249. 10.1016\/s0002-9149(01)02251-2","journal-title":"Am J Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis NG","year":"2002","unstructured":"Frangogiannis NG, Smith CW, Entman ML . The inflammatory response in myocardial infarction. Cardiovasc Res. 2002, 53:31-47. 10.1016\/s0008-6363(01)00434-5","journal-title":"Cardiovasc Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1096\/fj.99-0602fje","article-title":"Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment","volume":"14","author":"D'Amico M","year":"2000","unstructured":"D'Amico M, Di Filippo C, La M, et al.. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J. 2000, 14:1867-1869. 10.1096\/fj.99-0602fje","journal-title":"FASEB J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui F","year":"2006","unstructured":"Beygui F, Collet JP, Benoliel JJ, Vignolles N, Dumaine R, Barthe\u0301le\u0301my O, Montalescot G. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation. 2006, 114:2604-2610. 10.1161\/CIRCULATIONAHA.106.634626","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/222629-review-of-the-association-between-long-term-and-current-systemic-steroid-use-with-electromechanical-complications-and-inpatient-mortality-after-st-elevation-myocardial-infarction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T17:26:31Z","timestamp":1709141191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/222629-review-of-the-association-between-long-term-and-current-systemic-steroid-use-with-electromechanical-complications-and-inpatient-mortality-after-st-elevation-myocardial-infarction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.55154","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,28]]}}}